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Hepatopulmonary syndrome (HPS) is defined as an arterial oxygenation defect induced by
intrapulmonary vascular dilatations associated with hepatic disease. This study aimed to
assess the prevalence of type 1 and 2 pulmonary vascular abnormalities on chest computed
tomography (CT) in patients with cirrhosis and HPS and to characterize intra- and interob-
server reliability.
Materials and methods
Two thoracic radiologists retrospectively evaluated chest CT scans from 38 cirrhosis
patients with HPS. They classified the pulmonary vascular abnormalities as type 1 (multiple
dilated distal pulmonary arteries), type 2(nodular dilatation or individual pulmonary arterial
malformation), or absence of abnormality. Furthermore, they measured the diameters of the
central pulmonary arteries and subsegmental pulmonary arteries and bronchi. We analyzed
the prevalence, intraobserver reliability, and interobserver reliability of abnormal CT findings
related to HPS, and the correlation of these findings with partial arterial oxygen pressure
(PaO2).
Results
The overall prevalence of pulmonary vascular abnormalities was 28.9% (95% confidence
intervals: 15.4%, 45.9%). Moreover, 26.3% of patients had type 1 abnormality (13.4%,
43.1%) and 2.6% of patients had type 2 abnormality (0.0%, 13.8%). The intraobserver reli-
ability kappa value was 0.666 (0.40, 0.91) and the interobserver kappa value was 0.443
(0.12, 0.77). There was no correlation between pulmonary vascular abnormalities on CT
and PaO2 values.
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Conclusions
The prevalence of pulmonary vascular abnormalities on chest CT of patients with cirrhosis
and HPS is low and not correlated with PaO2. These findings question the usefulness of
chest CT for the evaluation of patients with cirrhosis and HPS.
Introduction
HPS affects 3–47% of patients with terminal liver disease depending on the diagnostic criteria
[1–5], and it is an independent risk factor for a worse prognosis among cirrhosis patients [5,6].
There is little, and contradictory, information regarding the use of thoracic computed
tomography (CT) scans for the diagnosis of HPS [1]. Initial data from a small study with only
10 patients reported that multiple dilated vessels with increased numbers of visible terminal
branches that extend to the pleura indicate a diagnosis of HPS [7]. Two subsequent studies in
individuals with cirrhosis and HPS reported an increased CT diameter of the peripheral pul-
monary vasculature compared with both healthy controls and patients with normoxemic cir-
rhosis [8,9]. In contrast, another study reported evidence of peripheral pulmonary artery
dilatation on CT in patients with liver disease compared with healthy controls, but no differ-
ences between patients with liver disease with or without HPS [10].
In addition, some authors [11,12] have extrapolated to CT data from a pulmonary angio-
graphic study of just 7 patients [13], which classified patterns of pulmonary vascular abnormal-
ities as type 1 (distal vascular dilatation with multiple vessels extending toward the pleura and
subpleural space) and type 2 (arteriovenous malformations and nodular dilatations of the
peripheral vessels). However, no previous studies have addressed the prevalence of these two
patterns of pulmonary vascular abnormalities in a larger sample of patients with HPS or evalu-
ated the reproducibility of CT pulmonary vasculature and bronchial-to-artery ratio measure-
ments in such patients.
Therefore, the purpose of this study was to assess the prevalence of type 1 and 2 pulmonary
vascular abnormalities on chest CT in patients with cirrhosis and HPS. We also aimed to char-
acterize intraobserver and interobserver reliability of qualitative and quantitative abnormal CT
findings related to HPS. Finally, we analyzed correlations between these findings and partial
arterial oxygen pressure (PaO2), a marker of disease severity.
Materials and methods
Patients
Data from consecutive patients of the pulmonary circulation clinic at a university tertiary care
hospital from January 2010 to December 2016 were reviewed. Patients were included where
they had a chest CT and a diagnosis of HPS based on the following criteria: (i) presence of
chronic liver disease; (ii) alveolar–arterial oxygen gradient (AaO2)>15 mmHg (20 mmHg in
patients over 64 years old) detected with blood gas analysis; and (iii) demonstration of intra-
pulmonary vascular dilatation by means of a positive contrast-enhanced echocardiography or
perfusion lung scanning with technetium-99m-labelled macroaggregated albumin [1,2].
Results from contrast-enhanced echocardiography, clinical exams, blood tests, and arterial
blood gas in room air were recorded from electronic patient records. Patients with a PaO2 in
room air below 80 mmHg were considered hypoxemic and above this as normoxemic [1]. The
maximum interval tolerated between chest CT and blood gas analysis was three months.
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Participants with pulmonary hypertension, bronchiectasis, interstitial lung disease, severe
chronic obstructive pulmonary disease, moderate/large pleural effusion, and/or those with
severe motion artefacts on chest CT were excluded.
The local institutional review board approved the study protocol. Due to its retrospective
nature the board waived the need for written informed consent. There are no conflicts of inter-
est to declare.
CT Acquisition and analysis
Images were obtained with a 8-multidetector row CT (MDCT) scanner (BrightSpeed Edge,
GE Medical Systems, USA), 16-MDCT scanner (Brilliance 16, Philips Healthcare, the Nether-
lands) or 64-MDCT scanner (Aquilion 64, Toshiba Medical Systems, Japan), with patients in
the supine position and at full inspiration. All scans were volumetric acquisitions (slice thick-
ness: 1.0–2.0 mm) and were reconstructed with a high spatial frequency algorithm. Images
were stored and analyzed with a picture and archiving communication system (IMPAX
6.6.1.3525, Aghfa HealthCare, Belgium) and all measurements were conducted by manually
placing an electronic caliper tool. When used, iodinated nonionic intravenous contrast media
was injected in a peripheral vein at a dose of 1–2 ml/kg of body weight.
Two thoracic radiologists (Observer 1 [LF], 5 years of experience, and observer 2 [JFZ], 3
years of experience) independently evaluated all the images. The diameters of the main pulmo-
nary artery, right and left pulmonary arteries, and subsegmental pulmonary arteries and bron-
chi were measured. When present, pulmonary vascular abnormalities were classified as type 1
or type 2. In case of discrepancies between the two assessors regarding the presence and type
of pulmonary vascular abnormality, a third independent thoracic radiologist (FST, 10 years of
experience) evaluated the images. Observer 1 performed all the measurements twice, with an
interval of six months to a year to prevent recall bias. Interobserver reliability was calculated
based on his first evaluation. Intraobserver reliability was calculated only for the observer 1.
Assessors were blinded to the clinical and laboratory parameters of the patients, as well as to
all measurements for the other assessors.
The presence of pulmonary vascular abnormalities, defined as Type 1 or Type 2, was evalu-
ated at lung window (W: 1500 HU, L: -500 HU). Type 1 abnormality (Fig 1) was defined as the
presence of dilated peripheral arteries that do not taper normally and that touch the pleural sur-
face in the lower lobes. Type 2 abnormality (Fig 2) was characterized by the presence of individ-
ual arteriovenous malformations and nodular dilatation of peripheral pulmonary vessels [12].
Quantitative assessment of peripheral arteries was performed by calculating the artery-to-
bronchus ratio (ABR). The ABR was defined as the ratio between the diameter of a 4th to 6th
generation subsegmental artery and the outer diameter of its accompanying bronchi in each
lower lobe. On lung window (W: 1500 HU, L: -600 HU), observers independently chose two
different subsegmental arteries and its accompanying bronchi in each lower lobe on a axial
image where both were rounded and parallel to each other. A single ABR value per patient was
calculated from the average of measurements performed in each lower lobe. Central pulmo-
nary arteries were measured at mediastinal window (W: 350 HU, L: 30 HU). The diameter of
the main pulmonary artery was measured at the level of its bifurcation, perpendicular to its
long axis. The diameters of the right and left pulmonary arteries were measured at their widest
portion before branching.
Statistical analysis
Statistical analysis was performed with SPSS version 20 (IBM, USA). Categorical variables are
presented as frequencies and percentages. Prevalence is presented with its respective 95%
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confidence interval (95%CI). Quantitative variables were evaluated for their symmetry with
the Kolmogorov Smirnov test and are presented as mean and standard deviation. Categorical
variables were evaluated with Chi-square test or Fisher’s exact test. Quantitative variables were
compared by using Student’s t-test for independent samples. A p-value of<0.05 was consid-
ered statistically significant.
To assess the concordance between categorical variables, the Kappa coefficient (K) of agree-
ment was used. Bland and Altman plots, and intraclass correlation coefficients (ICC) were
used to assess reliability among quantitative variables. Kappa and ICC values of 0.00–0.20 were
considered as slight agreement; 0.21–0.40 as fair agreement; 0.41–0.60 as moderate agreement;
0.61–0.80 as substantial agreement, and 0.81–1.00 as almost perfect agreement [14]. In addi-
tion, 95% CIs for each value of K and ICC were calculated.
Results
During the study period, 53 patients met the inclusion criteria. However, 15 patients were
excluded for the following reasons: large pleural effusion (n = 3); severe respiratory motion
artefacts on CT (n = 2); and an interval between chest CT and blood gas analysis greater than
three months (n = 10). The characteristics of the 38 patients included in the study are summa-
rized in Table 1.
The overall prevalence of either type 1 or type 2 pulmonary vascular abnormalities was
28.9% (95% CI: 15.4%, 45.9%), with 26.3% (13.4%, 43.1%) being Type 1 and 2.6% (0.1%,
13.8%) being Type 2 (Table 2). In the first analysis, Observer 1 identified Type 1 pulmonary
vascular abnormalities on CT in 10/38 patients (26.3%), Type 2 pulmonary vascular abnormal-
ity in 1/38 patient (2.6%), and no pulmonary vascular abnormality in 27/38 patients (71.1%).
In the second analysis, Type 1 abnormality was detected in 14/38 patients (36.8%), Type 2 in 1/
Fig 1. Type 1 pulmonary vascular abnormality. Type 1 pulmonary vascular abnormality was defined as the presence of dilated
peripheral arteries that do not taper normally and that touch the pleural surface in the lower lobes (arrows).
https://doi.org/10.1371/journal.pone.0223805.g001
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38 patient (2.6%), and no pulmonary vascular abnormality in 23/38 patients (60.5%). Observer
2 identified Type 1, Type 2, and no abnormality in 6/38 (15.8%), 1/38 (2.6%), and 31/38
patients (81.6%), respectively. The intraobserver Kappa value was 0.67 (95% CI: 0.40, 0.91;
p<0.001) and the interobserver Kappa value was 0.44 (95% CI: 0.12, 0.77; p = 0.02) (Table 3).
There was no difference in the prevalence of pulmonary vascular abnormalities when com-
paring normoxemic (n = 20) and hypoxemic patients (n = 18) (p = 0.513). The mean PaO2 of
patients with any vascular pulmonary abnormality on CT (n = 11) was 82.1 mmHg ± 17.9 and
for those without any pulmonary vascular abnormality (n = 27) it was 77.9 mmHg ± 15.8
(p = 0.515). There was no correlation between PaO2 and ABR (Fig 3).
Table 4 presents the measurements of the peripheral and central pulmonary vasculature.
Intra- and interobserver limits of agreement with the Bland and Altmann technique in measure-
ments of ABR, main pulmonary artery, right pulmonary artery, and left pulmonary artery are
shown in Figs 4 and 5. Values for intra- and interobserver reliability are presented in Table 3.
Discussion
Here, we demonstrate a low prevalence of pulmonary vascular abnormalities on chest CT in
patients with cirrhosis and HPS. Moreover, while this qualitative variable has good intraobser-
ver agreement, interobserver agreement was only moderate. Furthermore, intra- and interob-
server reliability and correlation with the Bland and Altmann technique of caliper-based
measurements of peripheral pulmonary vessels and ABR were poor. There was no correlation
Fig 2. Type 2 pulmonary vascular. Type 2 pulmonary vascular was characterized by the presence of individual arteriovenous
malformations and nodular dilatation of peripheral pulmonary vessels (arrows).
https://doi.org/10.1371/journal.pone.0223805.g002
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between abnormal CT findings and PaO2. This finding questions the usefulness of pulmonary
vascular assessment using thoracic CT in patients with cirrhosis and HPS.
Table 1. Patient demographics and clinical characteristics.
Variable Value
Male sex (%) 20 (52.6%)
Age (years) 54.11 ± 10.02
Liver disease etiology (%)




















PaO2 (mmHg) in room air 79.16 ± 16.30
AaO2 (mmHg) in room air 31.18 ± 14.32
Severity grade of HPS (%)
Mild (PaO2 �80 mmHg) 20 (52.6%)
Moderate (80 mmHg< PaO2�60 mmHg) 12 (31.6%)
Severe (60 mmHg< PaO2�50 mmHg) 2 (5.3%)
Very severe (PaO2 <50 mmHg) 4 (10.5%)
PaO2 (mmHg) in 100% O2 400.65 ± 110.47
Shunt (%) in 100% O2 15.62 ± 5.39





Intravenous contrast on CT (%)
Yes 15 (39.5%)
No 23 (60.5%)
Interval between CT and blood gas analysis (days) 35.0 ± 29.5
Note.–Mean values are provided with standard deviations. NASH = non-alcoholic steatohepatitis. MELD = Model
for End-Stage Liver Disease. COPD = chronic obstructive pulmonary disease. PaO2 = partial pressure of oxygen.
AaO2 = alveolar–arterial oxygen gradient. IPVD = Intrapulmonary vascular dilatation. CT = computed tomography
https://doi.org/10.1371/journal.pone.0223805.t001
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Table 2. Prevalence of peripheral pulmonary vascular abnormalities.
Type 1 Type 2
Prevalence 26.3% (13.4%, 43.1%) 2.6% (0.07%, 13.81%)
n 10/38 1/38
https://doi.org/10.1371/journal.pone.0223805.t002
Table 3. Intraobserver and interobserver reliability of qualitative and quantitative abnormal computed tomogra-
phy findings.
Intraobserver Interobserver
Pulmonary vascular abnormality K = 0.666 (0.40, 0.91) K = 0.443 (0.12, 0.77)
Artery-to-bronchus ratio ICC = 0.553 (0.287, 0.740) ICC = 0.368 (0.059, 0.613)
Main pulmonary artery ICC = 0.786 (0.626, 0.883) ICC = 0.837 (0.708, 0.912)
Right pulmonary artery ICC = 0.840 (0.713, 0.913) ICC = 0.827 (0.692, 0.906)
Left pulmonary artery ICC = 0.794 (0.638, 0.887) ICC = 0.844 (0.719, 0.916)
Note.–K = kappa coefficient. ICC = intraclass coefficient
https://doi.org/10.1371/journal.pone.0223805.t003
Fig 3. Linear correlation between PaO2 and ABR. Linear correlation between partial pressure of oxygen (PaO2) and the artery-to-bronchus ratio (ABR) for observer 1
and 2.
https://doi.org/10.1371/journal.pone.0223805.g003









Artery-to bronchus ratio 1.16 ± 0.11 1.12 ± 0.13 p = 0.03 0.89 ± 0.11 p = 0.01
Main pulmonary artery
(mm)
25.56 ± 2.52 25.55± 2.63 p = 0.90 24.98 ± 2.48 p = 0.01
Right pulmonary artery
(mm)
20.98 ± 2.30 21.42 ± 2.55 p = 0.059 20.51 ± 2.30 p = 0.03
Left pulmonary artery (mm) 20.42 ± 2.05 21.16 ± 2.21 p = 0.02 19.77 ± 1.98 p = 0.01
https://doi.org/10.1371/journal.pone.0223805.t004
Chest CT findings related to hepatopulmonary syndrome
PLOS ONE | https://doi.org/10.1371/journal.pone.0223805 October 18, 2019 7 / 11
No previous study has reported the prevalence of pulmonary vascular abnormalities on
chest CT and evaluated intra- and interobserver reliability of this qualitative finding. However,
one study reported prevalence of Type 1 (85%) and Type 2 pulmonary vascular abnormalities
(15%) in cirrhosis patients with HPS [13]. Interestingly, several authors have cited and refer-
enced these data, extrapolating the values to CT imaging [11, 12]. However, this prevalence
was established with conventional pulmonary angiography among just 7 patients and per-
formed by one observer [13]. Here, in a larger sample of 38 patients with cirrhosis and HPS,
we demonstrate a lower prevalence of pulmonary vascular abnormalities with chest CT.
The lower prevalence of pulmonary vascular abnormalities in our study may be due to the
spatial resolution of CT. Intrapulmonary vascular dilatation is characterized by dilatations of
alveolar septal arterioles and capillaries with a normal diameter of 7–15 μm to 15–150 μm [1,
15]. This is equivalent to the inferior limit of the minimum spatial resolution of CT (100–
300 μm) [16]. The lack of correlation between pulmonary vascular abnormalities and PaO2, a
marker of disease severity in HPS patients [1], may be because CT underestimates the presence
of dilatation of microscopic peripheral vessels.
The mean ABRs in our and other studies [7–10] are within the normal range reported for
healthy patients (0.98; 95% CI: 0.7, 1.26) [17]. Moreover, consistent with previous reports [10],
Fig 4. Intraobserver limits of agreement. Intraobserver limits of agreement with the Bland and Altmann technique.
https://doi.org/10.1371/journal.pone.0223805.g004
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ABR and PaO2 were not correlated. Chen et al. [10] compared patients with HPS and those
with liver dysfunction without HPS, reporting no difference in ABR. Our study reinforces the
hypothesis that dilatation of muscularized pulmonary arterioles is a consequence of the hyper-
dynamic circulatory state of cirrhosis mediated by vasoactive substances. Intrapulmonary vas-
cular dilatations constitute a distinct anatomic abnormality located distal to these vessels [10].
Two previous studies [8, 9] demonstrated higher ABRs in patients with HPS compared
with those with cirrhosis without HPS. Koksal et al. [8] reported a weak negative correlation (r
= -0.64; P = 0.04) between the diameters of right lower lobe basal segmental pulmonary arteries
and PaO2 in patients with HPS. This correlation may be higher than ours because one of the
10 patients had a basilar arterial diameter of 9 mm, which more likely represents a pulmonary
arteriovenous malformation [10]. Lee et al. [9] also demonstrated dilatation in peripheral pul-
monary vasculature in patients with cirrhosis and HPS. However, the presence of intrapul-
monary vascular dilatation was not confirmed with contrasted-enhanced echocardiography or
perfusion lung scanning with technetium-99m-labelled macroaggregated albumin.
Our study also illustrates the challenge of measuring small structures, such as subsegmental
arteries and bronchi, with CT in clinical practice. The diameters of central pulmonary vessels
had almost perfect intra- and interobserver agreement, while ABR had weak intra- and inter-
observer agreement. This is expected since reliability of measurements decreases as the size of
structures decrease [18]. In fact, manual tracing of inner and outer contours of the airway
cross-section on axial CT images suffers from large intra- and interobserver variability in
Fig 5. Interobserver limits of agreement. Interobserver limits of agreement with the Bland and Altmann technique.
https://doi.org/10.1371/journal.pone.0223805.g005
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airway measurement [19]. This may explain why we observed a significant difference in ABR
between observers. Automatic or semi-automatic ABR measurement could be an option.
However, these systems show large variation and fail to correctly pair arteries and airways in
21.9% of cases [20]. Given the weak interobserver reliability of ABR measurements in our and
other studies [19], the use of this technique to evaluate peripheral vascular dilatation is ques-
tionable and affects the external validity of previous papers.
Our study has several limitations, including its retrospective nature and the absence of a
specific thin slice high resolution CT protocol. Nonetheless, the slice thickness and the recon-
struction algorithms used are the ones currently selected in clinical practice. Additionally, the
3-month interval between CT and blood gas analysis may have affected the correlation
between PaO2 and the CT findings, particularly in borderline normoxemic or hypoxemic
patients.
In conclusion, this is the first study to access the prevalence of type 1 and 2 pulmonary vas-
cular abnormalities on chest CT in patients with cirrhosis and HPS (26.3% and 2.6%, respec-
tively). The prevalence of these abnormalities on Chest CT were not correlated with PaO2. The
intra- and interobserver reliabilities of this qualitative finding were only moderate. Our study
suggests that CT has a limited role in the diagnosis of HPS and its main utility remains in
excluding other underlying pulmonary diseases.
Supporting information
S1 Table. Data before analysis.
(XLS)
Author Contributions
Conceptualization: Luciano Folador, Felipe S. Torres, Juliana F. Zampieri, Betina C.
Machado, Marli M. Knorst, Marcelo B. Gazzana.
Data curation: Luciano Folador, Felipe S. Torres, Juliana F. Zampieri, Betina C. Machado.
Formal analysis: Luciano Folador.
Investigation: Luciano Folador, Felipe S. Torres, Juliana F. Zampieri, Betina C. Machado.
Methodology: Luciano Folador, Felipe S. Torres, Marli M. Knorst, Marcelo B. Gazzana.
Project administration: Luciano Folador, Marcelo B. Gazzana.
Supervision: Felipe S. Torres, Marli M. Knorst, Marcelo B. Gazzana.
Visualization: Felipe S. Torres, Marcelo B. Gazzana.
Writing – original draft: Luciano Folador, Felipe S. Torres, Marcelo B. Gazzana.
Writing – review & editing: Luciano Folador, Felipe S. Torres, Juliana F. Zampieri, Betina C.
Machado, Marli M. Knorst, Marcelo B. Gazzana.
References
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